(Q44752887)

English

Simvastatin and oseltamivir combination therapy does not improve the effectiveness of oseltamivir alone following highly pathogenic avian H5N1 influenza virus infection in mice

scientific article published in March 2013

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Simvastatin and oseltamivir combination therapy does not improve the effectiveness of oseltamivir alone following highly pathogenic avian H5N1 influenza virus infection in mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Kristy J Szretter

object named as

Kristy J Szretter

2

0 references

Jacqueline M. Katz

3

object named as

Jacqueline M Katz

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Terrence M Tumpey

4

object named as

Terrence M Tumpey

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Jessica A Belser

1

object named as

Jessica A Belser

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

language of work or name

0 references

publication date

1 March 2013

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

439

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

42-46

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Triple combinations of neuraminidase inhibitors, statins and fibrates benefit the survival of patients with lethal avian influenza pandemic

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.017

7 January 2021

Pathogenesis of pandemic influenza A (H1N1) and triple-reassortant swine influenza A (H1) viruses in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.017

7 January 2021

Host defense against viral infection involves interferon mediated down-regulation of sterol biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.017

7 January 2021

Impact of oral simvastatin therapy on acute lung injury in mice during pneumococcal pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.017

7 January 2021

Pre-admission statin use and in-hospital severity of 2009 pandemic influenza A(H1N1) disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.017

7 January 2021

Increased survival after gemfibrozil treatment of severe mouse influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.017

7 January 2021

Pandemic influenza: a potential role for statins in treatment and prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.017

7 January 2021

Simvastatin pretreatment prevents ambient particle-induced lung injury in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.017

7 January 2021

Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.017

7 January 2021

Susceptibility of highly pathogenic H5N1 influenza viruses to the neuraminidase inhibitor oseltamivir differs in vitro and in a mouse model.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.017

7 January 2021

Antiviral activity of lovastatin against respiratory syncytial virus in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.017

7 January 2021

Influenza virus neuraminidase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.017

7 January 2021

Oseltamivir-ribavirin combination therapy for highly pathogenic H5N1 influenza virus infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.017

7 January 2021

Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.017

7 January 2021

Anti-inflammatory effects of statins: clinical evidence and basic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.017

7 January 2021

Effect of statin treatments on highly pathogenic avian influenza H5N1, seasonal and H1N1pdm09 virus infections in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.017

7 January 2021

Statins as a newly recognized type of immunomodulator

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.017

7 January 2021

Influenza morbidity and mortality in elderly patients receiving statins: a cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.017

7 January 2021

A novel anti-inflammatory role for simvastatin in inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.017

7 January 2021

Evaluation of the efficacy and safety of a statin/caffeine combination against H5N1, H3N2 and H1N1 virus infection in BALB/c mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.017

7 January 2021

Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.017

7 January 2021

Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.017

7 January 2021

The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.017

7 January 2021

Simvastatin attenuates ventilator-induced lung injury in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.017

7 January 2021

The effect of rosuvastatin in a murine model of influenza A infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.017

7 January 2021

Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.017

7 January 2021

Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.017

7 January 2021

Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.017

7 January 2021

Association between use of statins and mortality among patients hospitalized with laboratory-confirmed influenza virus infections: a multistate study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.017

7 January 2021

Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.017

7 January 2021

Oseltamivir treatment of mice before or after mild influenza infection reduced cellular and cytokine inflammation in the lung

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.017

7 January 2021

Identifiers

10.1016/J.VIROL.2013.01.017

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44752887&oldid=2037490777"